IgGenix

Verified by our team

  • Research
Linkedin Twitter Facebook

IgGenix, a clinical-stage biotech company founded on innovations from Stanford’s Steve Quake and allergy expert Kari Nadeau, seeks motivated, organized individuals to join its South San Francisco team. Venture-backed, IgGenix focuses on advancing allergy treatment.

IgGenix Highlights:

  • IgGenix annual revenue is $2.5M.
  • IgGenix total funding is $75.0M.
  • IgGenix headquartered in South San Francisco, California.
  • IgGenix number of employees is 12.

    • Overview

    • Website: iggenix.com
    • Headquarters: South San Francisco, California
    • Employees: 12
    • Founded: 2019
    • Email: info@iggenix.com
    • Funding: $75.0M
    • Revenue: $2.5M
    • Valuation: n/a

    Contacts

    Jessica Grossman

    CEO
    Linkedin
    • Email: ***@iggenix.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to IgGenix

    IgGenix is located in South San Francisco, California.
    Yes, IgGenix is a Silicon Valley company.
    IgGenix total funding is 75.0M.
    IgGenix revenue is 2.5M.
    IgGenix’s number of employees is 12.
    IgGenix’s CEO name is Jessica Grossman.
    IgGenix was founded in 2019.
    IgGenix’s contact email is info@iggenix.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ